Synapse - Advancing global health equity in oncology clinical trial access

Advancing global health equity in oncology clinical trial access Editorial

Authors:	Bloomberg New Economy International Cancer Coalition; McKinsey Cancer Center; Cure4Cancer
Contributors:	Daly, B.; Li, B. T.; Abou-Alfa, G.; Anderson, S.; DeAngelis, L. M.; Diaz, L.; Drebin, J. A.; Isbell, J. M.; Jones, D. R.; Kingham, T. P.; Lee, N. Y.; Liu, D.; Makker, V.; McBride, S.; Norton, L.; Powell, S.; Razavi, P.; Rocco, G.; Rudin, C. M.; Scher, H. I.; Schrag, D.
Title:	Advancing global health equity in oncology clinical trial access
Abstract:	Despite exponentially increased industry investment in oncology research and development with more than $80 billion spent annually, patient enrollment in clinical trials remains below 5% globally. Our multistakeholder international cancer coalition envisions ecosystem transformation with capacity building through a global "hub-and-spoke" network model to expand access to and accelerate clinical trials, thus ending cancer as a major cause of death in this lifetime.
Journal Title:	Cancer Discovery
Volume:	14
Issue:	12
ISSN:	2159-8274
Publisher:	American Association for Cancer Research
Date Published:	2024-12-01
Start Page:	2317
End Page:	2323
Language:	English
ACCESSION:	WOS:001368753200014
DOI:	10.1158/2159-8290.Cd-24-1288
PROVIDER:	wos
PUBMED:	39315831
Notes:	The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Corresponding authors is MSK author: Bob T. Li -- Source: Wos